Related Experiment Video
Updated: Aug 5, 2026

09:36
Extracting Visual Evoked Potentials from EEG Data Recorded During fMRI-guided Transcranial Magnetic Stimulation
Published on: May 13, 2014
Opsoclonus-induced occipital deactivation with a region-specific distribution
B M de Jong1, T W van Weerden, R Haaxma
1Department of Neurology, University Hospital Groningen, POB 30.001, 9700 RB, Groningen, The Netherlands. b.m.de.jong@neuro.azg.nl
Vision Research
|April 9, 2001
Summary
Positron emission tomography (PET) revealed reduced glucose metabolism in the occipital lobe of a patient experiencing opsoclonus. This specific pattern suggests opsoclonus may disrupt visual motion processing.
Area of Science:
- Neuroscience
- Medical Imaging
- Neurology
Background:
- Opsoclonus is a rare neurological disorder characterized by involuntary, rapid eye movements.
- Understanding the underlying brain mechanisms of opsoclonus is crucial for diagnosis and treatment.
- Positron emission tomography (PET) with 2-[18F]fluoro 2-deoxy-D-glucose (FDG) is a functional imaging technique used to measure cerebral glucose metabolism.
Observation:
- Cerebral FDG uptake was measured in a patient with opsoclonus using PET.
- FDG distribution was compared between the opsoclonus patient and ten healthy individuals.
- Statistical parametric mapping (SPM) was employed for quantitative analysis of regional brain metabolism.
Findings:
- The opsoclonus patient exhibited decreased FDG uptake in the occipital lobe.
- Specific regions of reduced uptake included the posterior parieto-occipital sulcus (PO/V6), ventral to V5, and the anterolateral calcarine sulcus.
- This pattern indicates a localized occipital deactivation in the patient.
Implications:
- The observed occipital deactivation pattern may suggest that opsoclonus interferes with visual motion processing via the magnocellular pathway.
- This finding aligns with theories of normal saccadic suppression contributing to visual stability.
- Further research can explore the relationship between opsoclonus, visual processing deficits, and the magnocellular pathway.

